Zydus Lifesciences Ltd announced on Friday (November 7) that it has received tentative approval from the US Food and Drug ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Zydus Lifesciences announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Olaparib Tablets, used in the treatment of certain cancers.

Over the the next five years, up to 100,000 people in Ontario will be screened for genetic conditions that increase their ...

In 2012, at 46, Michelle discovered she carried the BRCA2 gene mutation — meaning she faced a higher risk of developing ...

Steve Merlin works with fellow pancreatic cancer patients, telling his remarkable story of surviving 13 years since his ...

The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world's first comprehensive center aimed at advancing ...

Jaime King opened up about her emotional experience wearing a bald cap for her ‘Love, Danielle’ role in an exclusive ...

Pancreatic cancer incidence is rising among younger adults, particularly those aged 15 to 39, due to lifestyle and genetic factors. Key risk factors include obesity, smoking, alcohol consumption, and ...

HealthDay News — For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR) gene alterations, the addition of niraparib to abiraterone acetate ...

Breast and ovarian cancers are among the deadliest threats to women’s health in their lifetime, hidden and complex in nature, ...